Related Experiment Video
Updated: Feb 10, 2026

Direct Drug Delivery to Kidney via the Renal Artery
Published on: April 17, 2021
Renal Pre-Competitive Consortium (RPC2): discovering therapeutic targets together
Mark Tomilo1, Heather Ascani1, Barbara Mirel2
1Internal Medicine, University of Michigan, Ann Arbor, MI 48103, USA.
Researchers formed the Renal Pre-Competitive Consortium (RPC^2) to improve kidney disease outcomes. This collaboration uses systems biology and shared data to accelerate the discovery of new therapies for renal disease.
Area of Science:
- Nephrology
- Genomics
- Systems Biology
Background:
- Patient outcomes in kidney disease have stagnated for 20 years.
- Identifying novel risk factors, progression markers, and therapies for renal disease is crucial.
- Genome-scale data analysis offers a platform to understand the molecular basis of kidney disease.
Purpose of the Study:
- To establish an academic-industry consortium to advance drug development for kidney diseases.
- To overcome challenges in expertise and resources for large-scale genomic studies in renal disease.
- To accelerate the identification of molecular targets for novel kidney disease therapies.
Main Methods:
- Formation of the Renal Pre-Competitive Consortium (RPC^2).
- Collaboration between academia and the pharmaceutical industry.
- Application of a systems biology approach to analyze genome-scale data.
Main Results:
- Establishment of a consortium to share expertise and resources.
- Initiation of molecular target identification efforts for kidney diseases.
- Development of a platform for understanding the molecular basis of renal disease.
Conclusions:
- The Renal Pre-Competitive Consortium (RPC^2) strategy facilitates collaborative research in kidney disease.
- This approach aims to accelerate the development of effective therapies for renal disease.
- Shared efforts in systems biology and genomics are vital for advancing nephrology research.
More Related Videos
13:48Discovering CsgD Regulatory Targets in Salmonella Biofilm Using Chromatin Immunoprecipitation and High-Throughput Sequencing ChIP-seq
Published on: January 18, 2020
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
Related Concept Videos
Competition
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Therapeutic Index
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...